Annual Meeting

Our coolest superpower: Seeing all the atoms

Jose A. Rodriguez Hosea Nelson
By Jose A. Rodriguez and Hosea Nelson
Sept. 19, 2023

Wouldn't it be great if we could just see all the atoms of all the molecules, any time we wanted?

If we were able to sample something — anything — and just tell what it's made of? Where all its atoms were? Which ones were connected or ready to react?

In about the span of a century, scientists have learned more about molecules and their components than we ever thought possible. In some cases, we can already pick up a bit of dust or a tiny droplet and see where the atoms of its resident molecules are. Or we can calculate predicted structures that are so accurate they can be used to predict function.

In old comic books, this kind of X-ray vision was the stuff of superheroes. Someday, in the not-too-distant future, we might all have it.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.

Join us for a glimpse into the challenges and opportunities of building that future, so we can all scrutinize, predict, build, target and react to all the molecules.

Keywords: Structure, cryo-electron microscopy, microcrystal electron diffraction, alpha fold, tomography, artificial intelligence.

Who should attend: Absolutely everyone should attend. Who doesn't want a superpower?

Theme song:Mosaic” by Art Blakey and the Jazz Messengers

This session is literally powered by electrons and photons.

New frontiers in structural biology

The rise of molecular assemblies

Chair: Rebecca Vorhees

Sarah ShahmoradianUniversity of Texas Southwestern Medical Center

Lorena SaelicesUniversity of Texas Southwestern Medical Center

New approaches enabling structural science

Chair: Jose Rodriguez

Roger Castells–GraellsUniversity of California, Los Angeles

Hosea NelsonCalifornia Institute of Technology

Hong ZhouUniversity of California, Los Angeles

Seeing the chemistry of life

Chair: Hosea Nelson

Lindsey R. F. Backman, Whitehead Institute for Biomedical Research

Douglas Rees, California Institute of Technology

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jose A. Rodriguez
Jose A. Rodriguez

Jose A Rodriguez is an associate professor of chemistry and biochemistry at UCLA.

Hosea Nelson
Hosea Nelson

Hosea Nelson is a professor of chemistry at the California Institute of Technology. His group focuses on new synthetic methods and structural elucidation tools.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Profile

Building a career in nutrition across continents

March 3, 2026

Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Journal News

Lipid-lowering therapies could help treat IBD

Feb. 25, 2026

Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
Journal News

Key regulator of cholesterol protects against Alzheimer’s disease

Feb. 24, 2026

A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.